AKUMIN INC (AKU) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AKU • US01021X1000

0.2887 USD
-0.06 (-17.87%)
At close: Oct 25, 2023
0.2875 USD
0 (-0.42%)
After Hours: 10/25/2023, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, AKU scores 2 out of 10 in our fundamental rating. AKU was compared to 102 industry peers in the Health Care Providers & Services industry. AKU may be in some trouble as it scores bad on both profitability and health. AKU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year AKU has reported negative net income.
  • In the past year AKU had a positive cash flow from operations.
AKU Yearly Net Income VS EBIT VS OCF VS FCFAKU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M -150M

1.2 Ratios

  • With a Return On Assets value of -9.35%, AKU is not doing good in the industry: 66.96% of the companies in the same industry are doing better.
  • The Return On Invested Capital of AKU (2.58%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for AKU is significantly below the industry average of 9.16%.
  • The 3 year average ROIC (1.89%) for AKU is below the current ROIC(2.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROIC 2.58%
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
AKU Yearly ROA, ROE, ROICAKU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 100 200 300

1.3 Margins

  • The Operating Margin of AKU (6.78%) is better than 72.17% of its industry peers.
  • AKU's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 25.32%, AKU is in line with its industry, outperforming 49.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AKU has declined.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 25.32%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
AKU Yearly Profit, Operating, Gross MarginsAKU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKU is destroying value.
  • The number of shares outstanding for AKU has been increased compared to 1 year ago.
  • AKU has a worse debt/assets ratio than last year.
AKU Yearly Shares OutstandingAKU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
AKU Yearly Total Debt VS Total AssetsAKU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 0.30, we must say that AKU is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AKU (0.30) is worse than 66.96% of its industry peers.
  • The Debt to FCF ratio of AKU is 59.58, which is on the high side as it means it would take AKU, 59.58 years of fcf income to pay off all of its debts.
  • AKU has a Debt to FCF ratio (59.58) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 59.58
Altman-Z 0.3
ROIC/WACC0.59
WACC4.35%
AKU Yearly LT Debt VS Equity VS FCFAKU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • AKU has a Current Ratio of 1.09. This is a normal value and indicates that AKU is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.09, AKU is not doing good in the industry: 70.43% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.09 indicates that AKU should not have too much problems paying its short term obligations.
  • AKU has a Quick ratio of 1.09. This is in the lower half of the industry: AKU underperforms 61.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
AKU Yearly Current Assets VS Current LiabilitesAKU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

5

3. Growth

3.1 Past

  • AKU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.41%.
  • Looking at the last year, AKU shows a very strong growth in Revenue. The Revenue has grown by 38.20%.
  • The Revenue has been growing by 59.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%

3.2 Future

  • Based on estimates for the next years, AKU will show a very strong growth in Earnings Per Share. The EPS will grow by 29.98% on average per year.
  • The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AKU Yearly Revenue VS EstimatesAKU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
AKU Yearly EPS VS EstimatesAKU Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AKU. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AKU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AKU Price Earnings VS Forward Price EarningsAKU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • AKU's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AKU is cheaper than 81.74% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AKU is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.18
EV/EBITDA 8.75
AKU Per share dataAKU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • AKU's earnings are expected to grow with 29.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • AKU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKUMIN INC

NASDAQ:AKU (10/25/2023, 8:00:00 PM)

After market: 0.2875 0 (-0.42%)

0.2887

-0.06 (-17.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-09
Earnings (Next)11-07
Inst Owners0%
Inst Owner Change0%
Ins Owners15.75%
Ins Owner Change0%
Market Cap25.84M
Revenue(TTM)750.96M
Net Income(TTM)-161.10M
Analysts45
Price Target0.92 (218.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-60.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 1.18
P/OCF 0.44
P/B N/A
P/tB N/A
EV/EBITDA 8.75
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)0.25
FCFY84.98%
OCF(TTM)0.66
OCFY229.66%
SpS8.39
BVpS-0.93
TBVpS-13.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROCE 3.26%
ROIC 2.58%
ROICexc 2.65%
ROICexgc 11.22%
OM 6.78%
PM (TTM) N/A
GM 25.32%
FCFM 2.92%
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
ROICexc(3y)1.99%
ROICexc(5y)2.97%
ROICexgc(3y)6.74%
ROICexgc(5y)9.33%
ROCE(3y)2.39%
ROCE(5y)3.5%
ROICexgc growth 3Y33.83%
ROICexgc growth 5Y32.54%
ROICexc growth 3Y18.03%
ROICexc growth 5Y32.94%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 59.58
Debt/EBITDA 8.69
Cap/Depr 38.76%
Cap/Sales 4.98%
Interest Coverage 0.76
Cash Conversion 40.27%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 0.3
F-Score4
WACC4.35%
ROIC/WACC0.59
Cap/Depr(3y)38.9%
Cap/Depr(5y)51.85%
Cap/Sales(3y)4.13%
Cap/Sales(5y)4.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y270.48%
EBIT growth 3Y64.54%
EBIT growth 5Y115.95%
EBIT Next Year262.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.58%
FCF growth 3Y436.48%
FCF growth 5YN/A
OCF growth 1Y59.77%
OCF growth 3Y121.33%
OCF growth 5Y94.79%

AKUMIN INC / AKU FAQ

Can you provide the ChartMill fundamental rating for AKUMIN INC?

ChartMill assigns a fundamental rating of 3 / 10 to AKU.


What is the valuation status for AKU stock?

ChartMill assigns a valuation rating of 3 / 10 to AKUMIN INC (AKU). This can be considered as Overvalued.


How profitable is AKUMIN INC (AKU) stock?

AKUMIN INC (AKU) has a profitability rating of 3 / 10.


Can you provide the financial health for AKU stock?

The financial health rating of AKUMIN INC (AKU) is 1 / 10.